Usual interstitial pneumonia

被引:42
作者
Lynch, Joseph P., III
Saggar, Rajan
Weigt, S. Sam
Zisman, David A.
White, Eric S.
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm Crit Care Med & Hosp, Dept Internal Med, Los Angeles, CA 90095 USA
[2] Univ Michigan, Med Ctr, Div Pulm & Crit Care Med, Ann Arbor, MI USA
关键词
usual interstitial pneumonia (UIP); idiopathic pulmonary fibrosis (IPF); cryptogenic fibrosing alveolitis (CFA); fibroblast; fibroblastic foci; honeycombing;
D O I
10.1055/s-2006-957335
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Usual interstitial pneumonia (UIP) is a distinct histological lesion observed in idiopathic pulmonary fibrosis (IPF) but can be found in other etiologies. The diagnosis of UIP can be established by surgical lung biopsy or by high-resolution thin-section computed tomographic (CT) scans (provided the radiographic features are classical). Historically, patients labeled as "IPF" encompassed a group of disorders, including UIP as well as other idiopathic interstitial pneumonias that differ from UIP in prognosis and responsiveness to therapy. Current recommendations from international consensus statements restrict the term IPF to patients with idiopathic UIP. The inciting cause(s) and pathogenesis of UIP have not been elucidated, but alveolar epithelial cell injury and dysregulation or altered phenotypic expression of fibroblasts are key elements. Inflammatory cells may play minor roles in initiating or propagating the fibrotic process. The prognosis of UIP is poor. Mean survival following diagnosis approximates 3 years. Current therapies are of unproven value. Corticosteroids or immunosuppressive agents have been most often used, but data affirming benefit are lacking. Lung transplantation is a viable option for patients failing medical therapy. This review discusses diagnostic criteria for UIP (both histopathological and radiographic), natural history and clinical course, and therapeutic approaches (both current and future).
引用
收藏
页码:634 / 651
页数:18
相关论文
共 251 条
  • [61] Idiopathic pulmonary fibrosis - Predicting response to therapy and survival
    Gay, SE
    Kazerooni, EA
    Toews, CB
    Lynch, JP
    Gross, BH
    Cascade, PN
    Spizarny, DL
    Flint, A
    Schork, MA
    Whyte, RI
    Popovich, J
    Hyzy, R
    Martinez, FJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (04) : 1063 - 1072
  • [62] IMMUNE-COMPLEXES, GALLIUM LUNG SCANS, AND BRONCHOALVEOLAR LAVAGE IN IDIOPATHIC INTERSTITIAL PNEUMONITIS-FIBROSIS
    GELB, AF
    DREISEN, RB
    EPSTEIN, JD
    SILVERTHORNE, JD
    BICKEL, Y
    FIELDS, M
    BORDER, WA
    TAYLOR, CR
    [J]. CHEST, 1983, 84 (02) : 148 - 153
  • [63] BALF N-acetylglucosaminidase and β-galactosidase activities in idiopathic pulmonary fibrosis
    Gessner, C
    Wirtz, H
    Sack, U
    Winkler, J
    Stiehl, P
    Schauer, J
    Wolff, G
    [J]. RESPIRATORY MEDICINE, 2002, 96 (09) : 751 - 756
  • [64] Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
    Ghofrani, HA
    Wiedemann, R
    Rose, F
    Schermuly, RT
    Olschewski, H
    Weissmann, N
    Gunther, A
    Walmrath, D
    Seeger, W
    Grimminger, F
    [J]. LANCET, 2002, 360 (9337) : 895 - 900
  • [65] Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis
    Greene, KE
    King, TE
    Kuroki, Y
    Bucher-Bartelson, B
    Hunninghake, GW
    Newman, LS
    Nagae, H
    Mason, RJ
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (03) : 439 - 446
  • [66] Determination of gamma/delta and other T-lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood from patients with sarcoidosis and idiopathic fibrosis of the lung
    Gruber, R
    Pforte, A
    Beer, B
    Riethmuller, G
    [J]. APMIS, 1996, 104 (03) : 199 - 205
  • [67] Genetics of fibrosing lung diseases
    Grutters, JC
    du Bois, RM
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (05) : 915 - 927
  • [68] Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis
    Günther, A
    Schmidt, R
    Nix, F
    Yabut-Perez, M
    Guth, C
    Rosseau, S
    Siebert, C
    Grimminger, F
    Morr, H
    Velcovsky, HG
    Seeger, W
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (03) : 565 - 573
  • [69] The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
    Hallstrand, TS
    Boitano, LJ
    Johnson, WC
    Spada, CA
    Hayes, JG
    Raghu, G
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (01) : 96 - 103
  • [70] THE IMPACT OF SMOKING ON MECHANICAL-PROPERTIES OF THE LUNGS IN IDIOPATHIC PULMONARY FIBROSIS AND SARCOIDOSIS
    HANLEY, ME
    KING, TE
    SCHWARZ, MI
    WATTERS, LC
    SHEN, AS
    CHERNIACK, RM
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05): : 1102 - 1106